U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination

3-methylglutaconic aciduria type 7

MedGen UID:
907853
Concept ID:
C4225393
Disease or Syndrome
Synonyms: 3-methylglutaconic aciduria type VII; 3-methylglutaconic aciduria, cataract, neurologic involvement, neutropenia syndrome; CLBP (ClpB homolog, mitochondrial AAA ATPase chaperonin) deficiency; MGA7 - 3-methylglutaconic aciduria type 7
SNOMED CT: MGA7 - 3-methylglutaconic aciduria type 7 (764860006); 3-methylglutaconic aciduria type VII (764860006); 3-methylglutaconic aciduria type 7 (764860006); 3-methylglutaconic aciduria, cataract, neurologic involvement, neutropenia syndrome (764860006); CLBP (ClpB homolog, mitochondrial AAA ATPase chaperonin) deficiency (764860006)

Definition

A rare disorder with characteristics of neurological problems and neutropenia. Onset of symptoms is in early childhood and severity varies widely among affected individuals. In the most severely affected individuals, features are apparent in infancy and sometimes at birth. Associated with congenital cataracts or cataracts in infancy. The disease is caused by mutations in the CLPB gene which is likely to reduce or eliminate the amount of functional CLPB protein. The severity of the disease may be related to the amount of functional protein that remains. Inherited in an autosomal recessive pattern. [from SNOMEDCT_US]

Recent clinical studies

Etiology

Wortmann SB, Vaz FM, Gardeitchik T, Vissers LE, Renkema GH, Schuurs-Hoeijmakers JH, Kulik W, Lammens M, Christin C, Kluijtmans LA, Rodenburg RJ, Nijtmans LG, Grünewald A, Klein C, Gerhold JM, Kozicz T, van Hasselt PM, Harakalova M, Kloosterman W, Barić I, Pronicka E, Ucar SK, Naess K, Singhal KK, Krumina Z, Gilissen C, van Bokhoven H, Veltman JA, Smeitink JA, Lefeber DJ, Spelbrink JN, Wevers RA, Morava E, de Brouwer AP
Nat Genet 2012 Jun 10;44(7):797-802. doi: 10.1038/ng.2325. PMID: 22683713

Diagnosis

Huna-Baron R, Yahalom G, Anikster Y, Ben Zeev B, Hoffmann C, Hassin-Baer S
J Neuroophthalmol 2022 Mar 1;42(1):e147-e152. Epub 2021 Apr 14 doi: 10.1097/WNO.0000000000001249. PMID: 33870938
Engelke UF, Kremer B, Kluijtmans LA, van der Graaf M, Morava E, Loupatty FJ, Wanders RJ, Moskau D, Loss S, van den Bergh E, Wevers RA
NMR Biomed 2006 Apr;19(2):271-8. doi: 10.1002/nbm.1018. PMID: 16541463

Prognosis

Huna-Baron R, Yahalom G, Anikster Y, Ben Zeev B, Hoffmann C, Hassin-Baer S
J Neuroophthalmol 2022 Mar 1;42(1):e147-e152. Epub 2021 Apr 14 doi: 10.1097/WNO.0000000000001249. PMID: 33870938

Clinical prediction guides

Engelke UF, Kremer B, Kluijtmans LA, van der Graaf M, Morava E, Loupatty FJ, Wanders RJ, Moskau D, Loss S, van den Bergh E, Wevers RA
NMR Biomed 2006 Apr;19(2):271-8. doi: 10.1002/nbm.1018. PMID: 16541463

Supplemental Content

Table of contents

    Recent activity

    Your browsing activity is empty.

    Activity recording is turned off.

    Turn recording back on

    See more...